Thank you for visiting our booth at ECP 2018 conference
If you did not have a chance to visit our booth or symposium or would like access to the scientific talk presented at the conference, here is an opportunity to download all the information you need.
Advances in our knowledge about tumour evolution, resistance development mechanisms and immuno-oncology, are leading towards changing the standard of care in many types of cancer. Continuous new biomarker implementation is becoming a norm for pathology laboratories and standardisation of the tests is a key requirement.
Tumor mutation burden as predictive biomarker from discovery to standardization
Dr. Nicola Normanno
INT-Fondazione Pascale
Department of Experimental Oncology
Naples
Tumour mutational burden and its transition towards the clinic
Prof. Dr. Wolfram Jochum
Institut für Pathologie
Kantonsspital St. Gallen
Liquid biopsy:
the experience of real life case studies
Dr. Beatriz Bellosillo
Laboratori de Diagnòstic Molecular
Hospital Del Mar
Barcelona
Implementing next generation sequencing in a pathology laboratory
Prof. Dr. José Luis Rodríguez Peralto
Hospital Universitario 12 de Octubre
Madrid
Tumor mutation burden as predictive biomarker from discovery to standardization
Dr. Nicola Normanno
INT-Fondazione Pascale
Department of Experimental Oncology
Naples
Tumour mutational burden and its transition towards the clinic
Prof. Dr. Wolfram Jochum
Institut für Pathologie
Kantonsspital St. Gallen
Liquid biopsy:
the experience of real life case studies
Dr. Beatriz Bellosillo
Laboratori de Diagnòstic Molecular
Hospital Del Mar
Barcelona
Implementing next generation sequencing in a pathology laboratory
Prof. Dr. José Luis Rodríguez Peralto
Hospital Universitario 12 de Octubre
Madrid
For Research Use Only. Not for use in diagnostic procedures.